You are here

PORTABLE IMAGING DEVICE FOR PROSTATE CANCER DETECTION

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44CA082620-02A1
Agency Tracking Number: CA082620
Amount: $0.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2002
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
ARTANN LABORATORIES, INC. 1753 LINVALE HARBOURTON RD
LAMBERTVILLE, NJ 08530
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 ARMEN SARVAZYAN
 (609) 333-0710
 ARMEN@ARTANNLABS.COM
Business Contact
 ARMEN SARVAZYAN
Phone: (609) 333-0710
Email: ARMEN@PLUTO.NJCC.CON
Research Institution
N/A
Abstract

Description (provided by applicant): The goal of the project is to develop a
portable cost-effective device for Mechanical Imaging (MI) of the prostate
capable of evaluating mechanical properties and geometry of the prostate. The
device comprises a transrectal probe, a compact electronic data acquisition
unit and a laptop PC. Information on diagnostically relevant mechanical and
geometrical characteristics of the prostate is obtained with the use of a force
sensor array and a motion-tracking sensor mounted on the probe. In Phase I, a
fully functional prototype of the Prostate Ml System has been built and
validated. Preliminary clinical studies have demonstrated that the sensitivity
of this device in detecting hard nodules within the prostate exceed that of a
digital rectal examination performed by trained urologists. In Phase II, a
preproduction prototype of the Prostate MI system for subsequent
commercialization will be developed. This design will include a compact
accelerometer-based motion tracking system, an optimized force sensor array,
and electronic hardware and software for real time imaging capability. The
final prototype will be validated in the laboratory setting and through the
comprehensive clinical trials at the Thomas Jefferson University Hospital and
the University of Michigan Medical Center.
PROPOSED COMMERCIAL APPLICATIONS:
Prostate Mechanical Imaging device will be positioned in the market as a cost-effective, portable and easy-to-use tool for prostate cancer diagnosis and screening. There is a tremendous need and commercial potential for this technology in the $50 billion prostate-related market with estimated 40-60 million adult males suffering from one or more prostate conditions. Industry analysts believe that only 10-15% of incidents are reported, stressing the urgent need for the new screening technology.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government